Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,174Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M22.0EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)15.2Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %3.7PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M81,500,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PID

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

PID is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

PID: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Atkinson, Richard Collier10% Security Holder 2016-05-06Buy169,000$0.0817912.5view
Reeson, DouglasDirector, Senior Officer 2016-05-06Buy100,000$0.0347933.33view
Crossett, Paul Everett10% Security Holder 2016-05-06Buy61,000$155-90.7view
Bal, Jatinder SinghIssuer 2016-05-06Sell20,000$0.0623916.67view
Bowerman, GordonDirector 2016-05-05Buy5,000$1.071246.73view
Yamini, BahmanDirector, Senior Officer 2016-05-03Buy5,000$0.236165.22view
Buskard, James LivingstoneSenior Officer 2016-05-02Sell50,000$0.552520view
Bal, Jatinder SinghDirector 2016-05-02Sell125,000$0.114310view
Bal, Jatinder SinghIssuer 2016-05-02Sell30,000$0.0528720view
Dubuc, PhilippeSenior Officer 2016-04-08Buy1,700$1.99624.12view

Quarterly/Annual Reports about PID:

    News about PID:

    Articles On GuruFocus.com
    Searching The World For The Best Dividend Stocks Jan 06 2015 

    More From Other Websites
    Major Developments for Sanofi in 1Q16 May 25 2016
    Sanofi’s Diabetes and Cardiovascular Franchise Performance May 24 2016
    New International Dividend Growth ETF by iShares in Focus May 24 2016
    Why PotashCorp’s Gross Margins Fell in 1Q16 May 20 2016
    A Peek at Sanofi’s Valuation Cheat Sheet May 19 2016
    Novo’s Geographical Sales Split in 1Q16 May 06 2016
    Why Did Agrium Perform Better Than Expected in 1Q16? May 06 2016
    Low U.S. Interest Rates Boost International Dividend ETFs May 05 2016
    How Did GlaxoSmithKline’s Global Pharmaceuticals Business Perform? May 05 2016
    4 Best Dividend-Paying European Equity ETFs (FDD, IDVY) May 05 2016
    How Has Novo’s Share Price Performed since Its Last Earnings? May 02 2016
    PotashCorp Missed 1Q16 Estimates: What’s Next? May 02 2016
    What Analysts Expect for CF Industries’ Gross Margins May 01 2016
    Will Agrium Report a Dip in Sales in 1Q16? Apr 27 2016
    Novartis’s Pharmaceutical Revenue Reported Growth in 1Q16 Apr 27 2016
    PID: An ETF Performance Case Study Apr 20 2016
    Oil Prices Are Tethered to Loads Of Overseas Stock ETFs, Too Apr 19 2016
    Victoza to Fuel Growth for Novo Nordisk Apr 15 2016
    Inside WisdomTree's New Dividend Growth ETF Apr 15 2016
    Analyzing Novo’s Haemophilia and Growth Hormone Portfolio Apr 13 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)